Tirzepatide fatigue: distinguishing the real causes
Fatigue on tirzepatide has multiple distinct causes (calorie deficit, GI distress, sleep changes, iron deficiency). The diagnostic approach matters more than the symptom.
The mechanism
Tirzepatide doesn't directly cause fatigue. The drug is not catabolic, doesn't suppress thyroid function at clinical doses, doesn't directly affect cortisol. What patients report as 'fatigue' on tirzepatide is downstream of the metabolic shift the drug produces: reduced caloric intake, reduced glucose substrate, possible iron and B12 depletion from rapid weight loss, changes in sleep architecture, and occasionally just dehydration.
What to expect
Most patients feel some fatigue in weeks 1-3 as the body adapts to lower caloric intake. By week 4-6, energy typically returns toward baseline or slightly above (improved metabolic state, less inflammation, better sleep in many patients). Persistent fatigue past week 8 is uncommon and usually has an identifiable cause.
Management
Differential diagnosis: (1) Calorie-deficit fatigue: are you eating enough total calories? Track for 14 days. The fix is eating more, especially protein. (2) GI-distress fatigue: persistent nausea or constipation drains energy. Address the underlying side effect. (3) Iron deficiency: rapid weight loss and altered absorption can deplete iron. Ferritin under 30 with fatigue warrants oral iron replacement. (4) Sleep disruption: the first 4-6 weeks often produce lighter, more fragmented sleep. Usually self-resolves. (5) Thyroid changes: rare but worth a TSH check if fatigue persists past month 3 with no other explanation.
When to escalate
Severe fatigue that prevents daily functioning warrants a workup: CBC (anemia), basic metabolic panel (kidney + electrolytes), TSH (thyroid), ferritin (iron stores), B12. Sudden onset severe fatigue with chest pain, shortness of breath, or palpitations suggests cardiac involvement; ER evaluation.
- SURMOUNT-1 (Jastreboff et al., NEJM 2022)